GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of help me understand T2D, I have read the wiki twice — 38 comments in the full submission. View in context.
1.1k
c/t2dglp1·submitted 2 months ago by u/joaquin_trevino

help me understand T2D, I have read the wiki twice

Discussionbranch of 6 comments

help me understand T2D, I have read the wiki twice. I am not trying to be the "source?" guy. I would just like a source. Postprandial excursions typically respond earlier than fasting glucose, so the sequence people observe is not a sign that something is not working. Sensor accuracy varies across wear, and readings…

Read the full submission and all 38 comments →

This branch

6 comments, started 2 months ago
u/rui_only_ro113 points·2 months ago

Push back: one sensor reading is not a data point worth acting on, especially in the first day of wear.

replysharereportpermalink
u/fasting_insulin_f70 points·2 months ago

Push back: one sensor reading is not a data point worth acting on, especially in the first day of wear.

Agreed, and the glucose-dependence point is the reason the risk profile reads the way it does.

replysharereportpermalink
u/joaquin_trevinoOP50 points·2 months ago

Correcting myself: 22 weeks between those two A1c results, which is too short an interval to interpret.

replysharereportpermalink
u/marisol_moreau88 points·2 months ago

Yes — time in range tells you about variability, which the average deliberately hides.

replysharereportpermalink
u/joaquin_trevinoOP36 points·2 months ago

Correction: that trial is the diabetes programme and the figure you quoted is its glycaemic endpoint, not a weight result.

replysharereportpermalink
u/arne_amankwah29 points·2 months ago

Careful, that is a regimen change suggestion and it needs to come from whoever manages your diabetes.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.